Editorial Comment to Development and Validation of the JIKEI‐YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI‐Based Doublet Therapy
Yoichiro Tohi, Mikio Sugimoto. Editorial Comment to Development and Validation of the JIKEI‐YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI‐Based Doublet Therapy. // International Journal of Urology. – 2026. – DOI: 10.1111/iju.70693. – URL: https://onlinelibrary.wiley.com/doi/10.1111/iju.70693?af=R
Yoichiro Tohi & Mikio Sugimoto (2026). Editorial Comment to Development and Validation of the JIKEI‐YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI‐Based Doublet Therapy. International Journal of Urology. https://doi.org/10.1111/iju.70693
Yoichiro Tohi and Mikio Sugimoto. “Editorial Comment to Development and Validation of the JIKEI‐YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI‐Based Doublet Therapy.” International Journal of Urology, 2026. doi:10.1111/iju.70693.
@article{Tohi2026,
title = {Editorial Comment to Development and Validation of the JIKEI‐YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI‐Based Doublet Therapy},
author = {Tohi, Yoichiro and Sugimoto, Mikio},
journal = {International Journal of Urology},
year = {2026},
doi = {10.1111/iju.70693},
url = {https://onlinelibrary.wiley.com/doi/10.1111/iju.70693?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...